Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: Role of Trp112 (Trp111)

X-ray structure of the V301L aldo–keto reductase 1B10 complexed with NADP+ and the potent aldose reductase inhibitor fidarestat: Implications for inhibitor binding and selectivity

(2013) Francesc Xavier Ruiz et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Aldose reductase from Schistosoma japonicum: crystallization and structure-based inhibitor screening for discovering antischistosomal lead compounds

(2013) Jian Liu et al.   Parasites & Vectors

Inhibition of Human Aldose Reductase-Like Protein (AKR1B10) by ^|^#945;- and ^|^#947;-Mangostins, Major Components of Pericarps of Mangosteen

(2012) Midori Soda et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

AKR1B10 and its emerging role in tumor carcinogenesis and as a cancer biomarker

(2012) Shailendra Kapoor   INTERNATIONAL JOURNAL OF CANCER

Aldo-Keto Reductases 1B in Endocrinology and Metabolism

(2012) Emilie Pastel et al.   Frontiers in Pharmacology

Involvement of the aldo–keto reductase, AKR1B10, in mitomycin-c resistance through reactive oxygen species-dependent mechanisms

(2011) Toshiyuki Matsunaga et al.   ANTI-CANCER DRUGS

Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo–keto reductase 1B10

(2011) Midori Soda et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

The molecular basis for inhibition of sulindac and its metabolites towards human aldose reductase

(2011) Xuehua Zheng et al.   FEBS LETTERS

Selective Inhibition of the Tumor Marker Aldo-keto Reductase Family Member 1B10 by Oleanolic Acid

(2011) Mayuko Takemura et al.   JOURNAL OF NATURAL PRODUCTS

PHENIX: a comprehensive Python-based system for macromolecular structure solution

(2010) Paul D. Adams et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Selective Inhibition of the Tumor Marker AKR1B10 by Antiinflammatory N-Phenylanthranilic Acids and Glycyrrhetic Acid

(2010) Satoshi Endo et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10

(2010) Satoshi Endo et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Structure of rat aldose reductase-like protein AKR1B14 holoenzyme: Probing the role of His269 in coenzyme binding by site-directed mutagenesis

(2010) Krithika Sundaram et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Kinetic studies of AKR1B10, human aldose reductase-like protein: Endogenous substrates and inhibition by steroids

(2009) Satoshi Endo et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: Probing the active site of the enzyme with molecular modeling and site-directed mutagenesis

(2009) Toshiyuki Matsunaga et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Aldo-keto Reductase Family 1 Member B10 Promotes Cell Survival by Regulating Lipid Synthesis and Eliminating Carbonyls

(2009) Chun Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY